Ani Pharmaceuticals (ANIP) Return on Sales [ROS] (2011 - 2026)
Ani Pharmaceuticals (ANIP) posted Return on Sales [ROS] of 15.21% for Q2 2026, up 8.64 percentage points from 6.57% a year earlier but down 1.17 percentage points from the prior quarter.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Return on Sales [ROS] (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Ani Pharmaceuticals was 15.37%, up 13.34 percentage points year-over-year; for FY2025, it came in at 12.58%, up 12.48 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of +20.26 percentage points (FY2020 to FY2025).
- In prior years, Ani Pharmaceuticals' Return on Sales [ROS] was 0.10% in FY2024 (-9.55 pp), 9.65% in FY2023 (+20.80 pp), -11.15% in FY2022 (+7.26 pp) and -18.41% in FY2021 (-10.73 pp).
- Quarterly Return on Sales [ROS] has run from a low of -38.94% in Q4 2021 to a high of 16.38% in Q1 2026 over five years.
- On a year-over-year basis, Return on Sales [ROS] has increased in each of the last five quarters, with an average year-over-year change of +3.04 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2022, with a gain of 40.87 percentage points; the weakest was Q4 2021, with a drop of 39.51 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 16.38% (Q1 2026), 14.07% (Q4 2025) and 15.91% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Ani Pharmaceuticals | 1.72 Bn | 502.13 Mn | 165.89 Mn | 15.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.21% |
| Mar 31, 2026 | 16.38% |
| Dec 31, 2025 | 14.07% |
| Sep 30, 2025 | 15.91% |
| Jun 30, 2025 | 6.57% |
| Mar 31, 2025 | 13.29% |
| Dec 31, 2024 | -2.30% |
| Sep 30, 2024 | -13.83% |
| Jun 30, 2024 | 3.74% |
| Mar 31, 2024 | 14.78% |
| Dec 31, 2023 | 5.11% |
| Sep 30, 2023 | 13.61% |
| Jun 30, 2023 | 10.64% |
| Mar 31, 2023 | 9.27% |
| Dec 31, 2022 | 1.93% |
| Sep 30, 2022 | -5.96% |
| Jun 30, 2022 | -17.48% |
| Mar 31, 2022 | -29.77% |
| Dec 31, 2021 | -38.94% |
| Sep 30, 2021 | -6.84% |
API Access
Ani Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();